Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia...
43 KB (3,613 words) - 02:13, 16 July 2024
(tafasitamab-cxix) , Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib). In 2013, Novartis acquired Incyte's c-Met...
11 KB (763 words) - 16:06, 3 June 2024
Remdesivir (section Remdesivir/baricitinib)
FDA issued an emergency use authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed...
113 KB (9,807 words) - 01:49, 16 July 2024
In June 2022, the U.S. Food and Drug Administration (FDA) authorized baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of severe alopecia...
43 KB (4,204 words) - 14:20, 13 July 2024
Administration (FDA) requires a boxed warning for the JAK inhibitors tofacitinib, baricitinib, and upadacitinib to warn about the risks of serious heart-related events...
36 KB (2,981 words) - 17:57, 23 June 2024
Management of hair loss (section Baricitinib)
alopecia spironolactone and flutamide. In June 2022, the FDA authorized baricitinib for the treatment of severe alopecia areata. Minoxidil, applied topically...
68 KB (7,160 words) - 18:52, 24 February 2024
crizotinib, daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib...
5 KB (232 words) - 10:23, 8 March 2024
Later that month, the WHO recommended the rheumatoid arthritis drug Baricitinib for severe or critical patients. It also recommended the monoclonal antibody...
367 KB (32,614 words) - 01:18, 14 July 2024
metaplasia with myelofibrosis and vitiligo. Examples are tofacitinib, baricitinib, upadacitinib and filgotinib. In 2014 researchers discovered that oral...
9 KB (974 words) - 14:46, 22 June 2024
"Bloomberg", February 9, 2017 Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase...
3 KB (156 words) - 10:21, 6 July 2024
which is in the public domain. "Frequently Asked Questions on Olumiant (Baricitinib) for the Treatment of COVID-19" (PDF). U.S. Food and Drug Administration...
128 KB (14,900 words) - 01:44, 16 July 2024
need systemic medicines such as cyclosporin, methotrexate, dupilumab or baricitinib. Other names of the condition include "infantile eczema", "flexural eczema"...
82 KB (8,521 words) - 21:01, 17 July 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
34 KB (3,877 words) - 13:28, 13 July 2024
FDA issued an emergency use authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed...
172 KB (19,547 words) - 09:25, 7 July 2024
(PDE4) inhibitor tsDMARD azathioprine Purine synthesis inhibitor unknown baricitinib JAK1 and JAK2 inhibitor tsDMARD certolizumab pegol TNF inhibitor bDMARD...
10 KB (869 words) - 20:47, 1 July 2024
Spondyloenchondrodysplasia (section Baricitinib)
headaches didn't stop, she was then prescribed a 2–4 mg daily dose of baricitinib, the latter medication significantly improved her serum ferritin levels...
27 KB (2,808 words) - 05:46, 8 April 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
26 KB (2,188 words) - 05:17, 13 June 2024
2022, the U.S. Food and Drug Administration (FDA) approved Olumiant (baricitinib) for adults with severe alopecia areatal. It is the first FDA approved...
48 KB (5,521 words) - 15:56, 9 July 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
26 KB (2,102 words) - 02:19, 16 July 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
31 KB (3,413 words) - 23:30, 21 June 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
33 KB (3,686 words) - 07:30, 20 May 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
62 KB (7,065 words) - 05:17, 28 June 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
26 KB (2,544 words) - 08:11, 4 July 2024
Drug Administration (FDA) requires a boxed warning for tofacitinib, baricitinib, and upadacitinib to include information about the risks of serious heart-related...
46 KB (4,534 words) - 06:57, 1 April 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
13 KB (1,176 words) - 21:00, 10 July 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
25 KB (2,614 words) - 22:42, 3 May 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
24 KB (1,700 words) - 04:21, 2 July 2024
Siponimod L04AE04 Ponesimod L04AE05 Etrasimod L04AF01 Tofacitinib L04AF02 Baricitinib L04AF03 Upadacitinib L04AF04 Filgotinib L04AF05 Itacitinib L04AF06 Peficitinib...
3 KB (367 words) - 15:37, 25 January 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
62 KB (6,833 words) - 02:25, 22 June 2024
Abrocitinib Baricitinib Filgotinib Momelotinib Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib) Upadacitinib JAK2 Atiprimod AZD-1480 Baricitinib CHZ868...
23 KB (2,088 words) - 01:05, 8 April 2024